Calgary, Alberta, Canada –TheNewswire -August 19, 2025 - Voyageur Pharmaceuticals Ltd. (VM:CA) (OTC Pink:VYYRF) (“Voyageur” or the “Company”), a company with a strategic focus on vertically ...
Positive feedback received after completion of CDC tests on 24 subjects All key product performance milestones met or exceeded expectations Voyageur believes it is now a player in the contrast media ...
Contrast agents like barium and iodine, which increase the visibility of medical imaging, are suffering from a global shortage, opening the growing US$6.3 billion dollar market up to new players ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results